Data Integrity - Requirements for a GMP-compliant Data Life Cycle
You can find all other dates of this seminar in this overview.
Speakers
Bob McDowall, R.D.McDowall Ltd.
Karl-Heinz Menges, Regierungspräsidium Darmstadt
Yves Samson, Kereon AG
Objectives
- Understand the current FDA and EU GMP regulations and guidance impacting data integrity from paper records to hybrid and electronic systems
- Understand the FDA requirements for data integrity and MHRA Data Integrity guidance March 2015
- Learn what is required for a data governance system from senior management through to staff in laboratories, manufacturing and quality assurance
- Understand the data life cycle and how it is linked with the business process and where problems can occur for both paper records, hybrid systems and electronic systems
Background
Data Integrity is a global problem and currently a major concern with FDA and European Regulatory Agencies. Multiple FDA warning letters and EU GMP non-compliance reports have highlighted major data integrity failures and falsification in companies globally. The regulatory concern has been responded by the FDA issuing Compliance Program Guide that covers Pre-Approval Inspections. This document became effective in May 2012. The CPG objective 3 covers the laboratory data integrity audit. Furthermore in August 2014, the FDA issued Level 2 guidance on their web site about the sharing of login credentials for computerized systems and the use of test injections for testing into compliance.
In Europe, the UK’s MHRA in December 2013 gave notice to regulated users to begin conducting data integrity audits of their own systems and those of their suppliers from the beginning of 2014. In January and March 2015, MHRA issued two versions of a Guidance for Industry on Data Integrity. This document outlines a data integrity governance system and principles for defining quality and data integrity into processes and systems. In addition, the guidance defines 19 terms and provides expectations and examples for many of them and therein is where the document’s value lies.
As the regulators are tightening their inspection approaches it is important that managers, supervisors and users in regulated GMP laboratories understand the issues around data integrity and begin programs to ensure that their processes and systems ensure data integrity.
Target Group
- Managers and staff from Manufacturing, QC/QA and Analytical Development Laboratories of pharmaceutical companies
- Contract Research Organisation and Contract Manufacturing Organisation manufacturing, laboratory and QA personnel
- Auditors (internal and external) responsible for performing self-inspections or external audits and needing to understand and assess data integrity
Programme
Why is Data Integrity Important? – Setting the Scene
- Summary of falsification observed by FDA and EU inspectors 2005 – to date
- FDAISA act 2012 and October 2014 Guidance for Industry and the impact on inspections
- Inspection of computerised systems is changing: from paper to on-line
- MHRA expectation for data governance; data integrity guidance documents 2015
- FDA Level 2 guidance on data integrity: 2010 and 2014 postings
- Impact of WHO guidance for data integrity
- EU GMP Chapter 4 – documentation
- EU GMP Annex 11 computerised systems
- Data integrity definitions
- Difference between paper and electronic systems
- The ALCOA+ criteria for data integrity
- Data life cycle in the process workflow – managing controls
- Paper versus hybrid versus electronic systems
- Validation of computerised systems for data integrity controls
- Scope: production information versus laboratory data: why are laboratory data higher risk?
- Data Governance System within the Pharmaceutical Quality System
- Data Life Cycle
- Spectrum of Systems: Paper to Electronic Systems with data integrity audit
- Background
- Questions and Answers regarding Data Integrity
- Role of Senior, Production and Department Management in ensuring data integrity within an organisation and its suppliers
- Data governance within a Quality System
- Failures to address poor data integrity practices and no training
- Within a PQS, what is the scope of a data governance system?
- Who are involved?
- What are their roles?
- Scope of data integrity training
- What cover in the training?
- Checking training effectiveness
- Integrating data integrity training with GMP training
- Why complete data and raw data are important for understanding data integrity
- EU GMP Chapter 4 requirements for raw data
- 21 CFR 211 requirements for laboratory records: complete data
- FDA Level 2 guidance: paper versus e-records
- Complete data / raw data / primary record example
- Lab System
- QA System
- Manufacturing System
- Configuration of CDS software
- SOP for integration
- Using samples for testing the System
- Understanding Annex 11 requirements for audit trails
- Differences between Part 11 and Annex 11 requirements for audit trail
- Default comments versus free text as reasons for change
- Review of audit trail entries: how to comply with Annex 11
- Reality v regulation: are audit trails in commercial products ready for Annex 11?
- User Account Management and Application
- Configuration
- Separation of roles and responsibilities between IT and the business
- Documentation of the configuration of an application e.g. audit trail, user types and access privileges
- User account management: the do’s and don’ts
- User identities must be unique
- Regular review of each system users and privileges
- IT facilities, environmental controls and physical security
- Qualified IT infrastructure and validated IT systems
- Backup and recovery / Change control
- IT support including database administration
- Impact of IT infrastructure on data integrity
- Regulatory compliance requirements to consider before going to the cloud
- Are ISO 27001 or SSAE 16 adequate to meet GMP regulations?
- Whose responsibility is data integrity when using the cloud?
- Cloud suppliers: are you dealing with a single entity?
- How to select a cloud supplier
- Problems with spreadsheets
- Good Practice for using spreadsheets in a regulated environment
- Building data integrity features into a spreadsheet
- Approaches to ensuring data integrity of your suppliers
- Role of technical agreements and audits
- Summary of Data Integrity Requirements and Key Learning Points
- Final Discussions and close of the course
- Recording results on paper
- Configuration of software applications
- Unique user identities for all users
- Unauthorised access
- Appropriate access privileges for each user role
- Is my chromatographic system ready? Role of “test” injections
- Audit trails – options for older systems
- Manual chromatographic integration
- Standalone versus network systems
- Protecting electronic records of standalone systems
- Working in teams, attendees will analyse one of several FDA warning letters to identify key areas of regulatory concern
- Group discussion of regulatory concerns identified
- Using a checklist based on the data integrity criteria, attendees will assess a system for data integrity
This course is part of the GMP Certification Programme "ECA Certified Computer Validation Manager" Learn more
This training/webinar cannot be booked. Send us your inquiry by using the following contact form.
To find alternative dates for this training/webinar or similar events please see the complete list of all events.
For many training courses and webinars, there are also recordings you can order and watch any time. Just take a look at the complete list of all recordings.
Not available
Not available
Not available
Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org
- Our Service
Testimonials- Your Certificate
Seminar Programme as PDF
